ORUKA THERAPEUTICS INC (ORKA:NASDAQ)
$84.56 -2.23 (-2.5694%)
Analysed ORUKA THERAPEUTICS INC (ORKA:NASDAQ) News Sources
Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120%
13-05-2026
fool.com
Oruka Therapeutics (ORKA) Valuation Check After Psoriasis Trial Progress Partnerships And Fresh Funding
15-05-2026
yahoo.com
Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
28-05-2026
yahoo.com
An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million
31-05-2026
fool.com
Wall Street Analysts Believe Oruka Therapeutics, Inc. (ORKA) Could Rally 111.13%: Here's is How to Trade
10-06-2026
yahoo.com
Oruka Therapeutics, Inc. (ORKA) Upgraded to Buy: What Does It Mean for the Stock?
12-06-2026
yahoo.com
Oruka Therapeutics' Head of Finance Sold Over 10,000 Company Shares. What Does That Mean for Investors?
24-06-2026
fool.com
Oruka Stock Is Now Up Nearly 700%. Here's What a $687,000 Insider Sale Could Mean
27-06-2026
fool.com
H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition News
01-07-2026
yahoo.com
HMI Capital Pares Its Stake in AI Company nCino
10-07-2026
yahoo.com
What is the current price of ORUKA THERAPEUTICS INC (ORKA:NASDAQ)?
The current price of ORUKA THERAPEUTICS INC (ORKA:NASDAQ) is $84.56.
ORUKA THERAPEUTICS INC (ORKA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ORUKA THERAPEUTICS INC (ORKA:NASDAQ) since the previous trading day is $-2.23.
ORUKA THERAPEUTICS INC (ORKA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ORUKA THERAPEUTICS INC (ORKA:NASDAQ) since the previous trading day is -2.5694%.
What is the most recent average sentiment score for ORUKA THERAPEUTICS INC (ORKA:NASDAQ)?
The most recent average sentiment score for ORUKA THERAPEUTICS INC (ORKA:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for ORUKA THERAPEUTICS INC (ORKA:NASDAQ)?
The most recent sentiment for ORUKA THERAPEUTICS INC (ORKA:NASDAQ) is .
SEC-8K** Filing Available For ORUKA THERAPEUTICS INC (ORKA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.